A conserved human germline V kappa gene directly encodes rheumatoid factor light chains.
Open Access
- 1 December 1986
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 164 (6) , 2119-2124
- https://doi.org/10.1084/jem.164.6.2119
Abstract
The full-length gene that encodes the light chain variable regions of an idiotypically related group of human IgM kappa rheumatoid factors (RFs) has been cloned and sequenced. The deduced amino acid sequence is identical to four separate RF proteins. These results prove that genes capable of encoding human anti-IgG autoantibody light chains without any somatic mutation are present in the kappa gene repertoire of normal people.This publication has 12 references indexed in Scilit:
- A single germline VH gene segment of normal A/J mice encodes autoantibodies characteristic of systemic lupus erythematosus.The Journal of Experimental Medicine, 1986
- Expression of three cross-reactive idiotypes on rheumatoid factor autoantibodies from patients with autoimmune diseases and seropositive adults.The Journal of Immunology, 1986
- Sequence similarities and cross-idiotypic specificity of L chains among human monoclonal IgM kappa with anti-gamma-globulin activity.The Journal of Immunology, 1985
- Characterization of human rheumatoid factors with seven antiidiotypes induced by synthetic hypervariable region peptides.The Journal of Experimental Medicine, 1985
- Preferential utilization of the most JH-proximal VH gene segments in pre-B-cell linesNature, 1984
- Somatic mutation of the T15 heavy chain gives rise to an antibody with autoantibody specificity.Proceedings of the National Academy of Sciences, 1984
- Lambda replacement vectors carrying polylinker sequencesJournal of Molecular Biology, 1983
- [2] New M13 vectors for cloningPublished by Elsevier ,1983
- DNA sequencing with chain-terminating inhibitorsProceedings of the National Academy of Sciences, 1977
- CROSS-IDIOTYPIC SPECIFICITY AMONG MONOCLONAL IGM PROTEINS WITH ANTI-γ-GLOBULIN ACTIVITYThe Journal of Experimental Medicine, 1973